Skip to main content
Premium Trial:

Request an Annual Quote

Genomatica, DSM Sign Multi-Year Collaboration, Licensing Agreement

NEW YORK, June 28 (GenomeWeb News) - Genomatica has signed a multi-year collaboration and licensing agreement with DSM, the firm said yesterday.

 

Under the terms of the agreement, Genomatica will provide DSM, a Dutch chemical and biotechnology firm, with its metabolic modeling and simulation technologies.

 

The pact builds on an earlier agreement between the two companies, and includes research and development support, technology license fees, and milestone payments. Financial details were not disclosed. 

 

Christophe Schilling, president and chief scientific officer at Genomatica, said in a statement that the company will provide integrated metabolic engineering solutions to DSM "for developing next-generation microbial bio-factories to produce valuable industrial products from sustainable feedstocks." 

 

DSM sells ingredients based on fermentation and enzyme technology to the chemical, pharmaceutical, and food industries.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.